IL2 and Sjogren syndrome: The lymphocytes in the salivary glands have been shown to produce IL-226 and IL-2 treatment has been shown to improve salivary secretions in a mouse model of Sjogren's syndrome,27 suggesting that Covid-19 could damage the salivary glands causing lower levels of salivary IL-2 and reduced salivary flow.